Inventia Life Science is advancing 3D bioprinting technology to revolutionise biomedical research and regenerative medicine. The company's strong foundation of fundamental research has led to the development of a proprietary platform encompassing bioprinting technology, an expanding library of printable bioink materials and custom protocols for specific applications. The RASTRUM platform is now available to enable efficient and powerful bioprinting of 3D cell-based assays for biomedical research.

Website: inventia.life

Employees: 50 - 99

HQ: N/A

Location: Suite 1.13 Alexandria, N/A, au

Revenue: 5 - 10 Million

Inventia Life Science is a leading biotechnology company that focuses on developing innovative solutions for the healthcare industry. With a team of experts in various fields, the company is committed to improving patient outcomes and quality of life. If you're looking for contact information for Inventia Life Science, ConnectPlex is the right place to be. Our platform offers a comprehensive database of company information, including contact details for key personnel and decision-makers. With ConnectPlex, you can easily connect with the right people at Inventia Life Science and explore potential business opportunities. At ConnectPlex, we understand the importance of accurate and up-to-date information. That's why we constantly update our database to ensure that our clients have access to the most recent contact information for Inventia Life Science and other companies. Our user-friendly platform makes it easy to search and filter through our database, so you can quickly find the contact information you need. With ConnectPlex, you can save time and resources while increasing your chances of success in business.

Inventia Life Science is a cutting-edge biotechnology company that is revolutionizing the field of biomedical research and regenerative medicine. Located in Suite 1.13 Alexandria, Australia, the company has developed a proprietary platform known as RASTRUM, which enables the efficient and powerful bioprinting of 3D cell-based assays. With a strong foundation of fundamental research and an expanding library of printable bioink materials, Inventia Life Science is at the forefront of advancing 3D bioprinting technology. Led by a team of experienced executives, including Chief Executive Officer Julio Medicine, Chief Product Officer Bob Groneman, and Co-Founder & Chief Operating Officer Cameron Ferris, the company is committed to transforming the way biomedical research is conducted. With its innovative technology and dedication to excellence, Inventia Life Science is poised to make a significant impact in the field of biotechnology.

Inventia Life Science is improving 3D bioprinting technology to change the way we do biomedical research and regenerative medicine. The company has a strong base of research that has led to the creation of a special platform that includes bioprinting technology, a growing library of materials that can be printed, and custom instructions for specific uses. The RASTRUM platform is now available to help scientists create 3D cell-based assays for biomedical research more quickly and effectively.